Clinical Trial Update: Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the efficacy of L-Ornithine L-Aspartate and polyethylene glycol in cirrhotic patients with overt hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• L-ornithine-L-aspartate (L-ornithine-L-aspartate)
• Polyethylene Glycol (polyethylene glycol)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Hepatic Encephalopathy Stage 2, Hepatic Encephalopathy Stage 3 | Phase 4 | Status: UNKNOWN